Ipsen (United States)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
338
Total Open
Publications
178
Total
Citations
4.1K
Open Access
Percentage
53%
Total
Publications
338
Total Open
Publications
178
Total
Citations
4.1K
Breakdown
Publisher Open
23%
Both
28%
Other Platform Open
2%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
43
Hybrid 61%
104
No Guarantees 14%
24
Other Platform Open
Domain 87%
87
Institution 17%
17
Public 15%
15
Other Internet 10%
10
Preprint 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 87 |
Europe PMC | Domain | 38 |
Semantic Scholar | Public | 10 |
Figshare | Public | 4 |
California Digital Library - eScholarship | Other Internet | 3 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 2 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University of Birmingham - University of Birmingham Research Portal | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 2 |